ILYANG PHARMACEUTICAL CO.,LTD
Develops and manufactures a diverse range of pharmaceuticals and consumer health products.
007570 | KO
Overview
Corporate Details
- ISIN(s):
- KR7007570005
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 하갈로 110, 용인시
- Website:
- https://www.ilyang.co.kr
- Sector:
- Manufacturing
Description
Ilyang Pharmaceutical, established in 1946, is a research-oriented company that develops and manufactures a diverse portfolio of pharmaceutical products. The company focuses on developing new chemical entities (NCEs) and produces a range of medicines targeting digestive, respiratory, and circulatory system disorders, as well as neoplasms and infectious diseases. Key developments include 'Ilaprazole' (Noltec), a proton pump inhibitor for acid-related disorders, and 'Supect' (Radotinib), a treatment for chronic myeloid leukemia. Its product line also encompasses general drugs, antibiotics, anti-inflammatory agents, nutritional supplements, and well-established consumer health brands like the digestive aid 'NORUMO' and the nutritional drink 'Wonbi-D'.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-13 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.6 KB | ||
| 2025-02-13 00:00 |
현금ㆍ현물배당결정
|
Korean | 9.0 KB | ||
| 2025-02-13 00:00 |
주요사항보고서(자기주식취득신탁계약체결결정)
|
Korean | 32.7 KB | ||
| 2025-01-31 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 14.2 KB | ||
| 2024-12-31 00:00 |
[기재정정]신규시설투자등
|
Korean | 10.8 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 1.4 MB | ||
| 2024-11-06 00:00 |
신탁계약해지결과보고서
|
Korean | 18.3 KB | ||
| 2024-10-18 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.1 KB | ||
| 2024-10-18 00:00 |
최대주주등소유주식변동신고서
|
Korean | 34.3 KB | ||
| 2024-10-17 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.9 KB | ||
| 2024-10-17 00:00 |
최대주주등소유주식변동신고서
|
Korean | 35.1 KB | ||
| 2024-10-08 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.1 KB | ||
| 2024-10-08 00:00 |
최대주주등소유주식변동신고서
|
Korean | 34.3 KB | ||
| 2024-09-27 00:00 |
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 24.7 KB | ||
| 2024-09-13 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 27.8 KB |
Automate Your Workflow. Get a real-time feed of all ILYANG PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ILYANG PHARMACEUTICAL CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ILYANG PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
